AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 381-400 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
381
Star Catcher Industries, Inc.
lowweak
Opp 1
Risk 2

Thesis: There is insufficient reviewed evidence in these reviewed sources to support an opportunity thesis beyond a broad statement that the company is building space infrastructure.

Why now: Why now is weak because the reviewed sources' membership rationale references article describing an orbital power grid concept, but no article or reviewed evidence are provided for ranking use.

Caveats: No article is available for article. Coverage debug shows zero evidence after recent evidence window. Cannot elevate concept relevance into thesis attractiveness without direct business evidence.

382
Star Catcher Industries, Inc.
lowweak
Opp 1
Risk 1

Thesis: Reviewed evidence-level rationale suggests Star Catcher is a space startup building space-based power infrastructure, but the ranking reviewed sources provide no direct positive evidence retained inside the 90-day recent evidence window, so there is insufficient basis for a positive 1 year+ opportunity thesis from admissible evidence.

Why now: Why now is weak because the company had 10 articles considered, but zero article IDs and zero evidence remained after the 90-day recent evidence window cutoff of March 29, 2026; recency-based business-state judgment is therefore unavailable from these reviewed sources.

Caveats: No retained evidence after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 membership rationale is not directional proof and cites support article IDs without, so it cannot be used as a fully cited factual thesis.

383
Starfighters Space
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources rationale suggests Starfighters Space has air-launch and hypersonic testing relevance, but no within the recent evidence window direct evidence or citable are present in the reviewed sources output, so that does not support a scored positive thesis here.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Starfighters Space.

Caveats: Phase-2 membership rationale references multiple article IDs, but the reviewed sources provide no article for citation.

384
Starfish Space
lowweak
Opp 1
Risk 1

Thesis: Membership rationale indicates autonomous proximity-operations progress, but no retained 90-day direct positive evidence is available in the served reviewed sources to support a durable upside thesis.

Why now: No retained article IDs or evidence remain after recent evidence filtering, so there is no current evidence-based catalyst in the reviewed sources.

Caveats: Single-article historical context is not retained within the recent evidence window. Absence of negative evidence is not positive evidence. Scoring is conservative because the current reviewed sources is effectively ungrounded for direction.

385
Starlab
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable because the reviewed sources retains no direct positive evidence within the recent evidence window.

Why now: Why now is weak: the reviewed sources indicates zero evidence after recent evidence window, so there is no retained current catalyst or current operating-state evidence for Starlab.

Caveats: Coverage after recent evidence window is empty for this company. Phase-2 membership rationale references, but no article summary or quoted evidence is included in the retained reviewed sources, so it cannot be used for factual claims here.

386
StatSat
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not retain sufficient company-specific positive evidence to support an opportunity thesis.

Why now: The membership rationale references article and says AISSat-4 is operated by StatSat, but no retained evidence or are present after recent evidence window, leaving recency and business impact uncertain.

Caveats: The only described support is a limited operational reference, not a clear catalyst. No direct dated evidence row is retained in the reviewed sources.

387
Swedish Space Corporation
lowweak
Opp 1
Risk 1

Thesis: No supported positive thesis from the retained recent evidence window evidence. The reviewed sources only notes an indirect mention of international partnerships involving Sweden in a Firefly earnings transcript summary, without clearly establishing Swedish Space Corporation's role or business impact (: no provided in reviewed sources).

Why now: There is no current catalyst supported by retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency and business-state changes cannot be assessed from these reviewed sources.

Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase2 rationale is weaker than direct company-specific event evidence and should not be treated as strong proof.

388
Swoop Technologies
lowweak
Opp 1
Risk 1

Thesis: The only reviewed sources support is review-status context that Swoop was placed among Golden Dome contract awardees for networking/simulation, which could indicate defense/space-adjacent participation, but there is no direct positive evidence row or in the reviewed sources to support a durable opportunity thesis (: not provided in reviewed sources).

Why now: No inside-recent evidence window evidence are available, and the reviewed sources reports articles after recent evidence window = 0 and evidence after recent evidence window = 0, so there is no supported near-term or long-horizon timing catalyst beyond generic context.

Caveats: Single-article company universe but no representative article content or provided. Contract-award framing comes only through membership rationale, not direct evidence. No materiality, scale, or timing detail is available.

389
TelePIX
lowweak
Opp 1
Risk 1

Thesis: Reviewed evidence membership rationale suggests TelePIX is a space AI solutions company partnering on a VLEO satellite mission with an optical payload, which could imply long-horizon product or mission traction, but the reviewed sources provide no retained article summaries or direct positive evidence within the 90-day recent evidence window to support a stronger opportunity case.

Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window, so there is no current retained catalyst evidence in the last 90 days despite membership support referencing article

Caveats: Support exists only in the membership rationale, which cites article: but no or article summary is provided in the reviewed sources, so it cannot be cited as a factual claim under the the evidence standard. Evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0.

390
Telesat Corp
lowweak
Opp 1
Risk 1

Thesis: No retained within the recent evidence window direct positive evidence is available in the reviewed sources, so there is not enough support for an opportunity thesis despite cohort relevance.

Why now: Coverage data reports zero article IDs after recent evidence window and zero evidence after recent evidence window, preventing a recency-based ranking call.

Caveats: Membership rationale references satellite communications and Lightspeed progress, but no article or retained evidence are supplied for ranking use. Public company status does not itself create a thesis without evidence.

391
Terran Orbital
lowweak
Opp 1
Risk 2

Thesis: The only reviewed sources support is a membership rationale stating Lockheed's modular satellite platform leverages Terran Orbital production, which suggests manufacturing relevance, but there is no in-window company evidence to support a stronger opportunity call.

Why now: There is no valid near-term or long-horizon catalyst from the reviewed sources because coverage data shows zero evidence after recent evidence window; current state cannot be confirmed from local evidence.

Caveats: No evidence remained after the 90-day recent evidence window. The reviewed sources includes only sparse membership rationale, not current direct evidence.

392
TESAT
lowweak
Opp 1
Risk 1

Thesis: TESAT appears in the reviewed sources only as a partner in Kepler Communications' ESA optical communications contract. Because relations are context-only in these reviewed sources, that cannot be used as direct counterparty propagation evidence, leaving no direct positive thesis support for TESAT itself (: not provided in reviewed sources).

Why now: No inside-recent evidence window direct evidence are available, so there is no supported timing argument.

Caveats: Relation evidence is context-only and cannot be propagated as direct contract evidence. No or representative article summary is provided. No company-specific materiality data is available.

393
TESAT Spacecom
lowweak
Opp 1
Risk 1

Thesis: TESAT Spacecom is only referenced in prior HydRON contract context involving other companies, which is too indirect to support a positive thesis under the the evidence standard.

Why now: There is no within the recent evidence window direct company evidence. Membership rationale references, but no is provided and the support level is only provisional single-article context.

Caveats: Support is explicitly supporting article context, not direct company-specific event evidence. No retained evidence after recent evidence window. Relations/context-only mentions cannot be used as counterparty propagation evidence.

394
Thales
lowweak
Opp 1
Risk 1

Thesis: A weak opportunity case exists only from the phase2 rationale, which says Thales Alenia Space was linked as prime contractor for Sentinel-1 Next Generation satellites, suggesting satellite manufacturing/radar exposure. However, the reviewed sources provide no available article summaries or evidence inside recent evidence window for Thales itself, and the rationale itself questions whether subsidiary evidence should propagate to the parent.

Why now: There is no citable in-recent evidence window article summary or evidence row for Thales in these reviewed sources, and coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase2 rationale references article ids: and: but no or summaries for them are included here. Parent/subsidiary propagation is explicitly uncertain in the reviewed sources rationale. No direct evidence were available after recent evidence window.

395
Trishul Space
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only says Trishul Space was placed in T-Hub's ORBIT spacetech accelerator context, which is not enough by itself to establish a durable positive 1 year+ thesis without direct company-specific progress evidence.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Trishul Space.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Accelerator participation context is weaker than direct commercial, funding, or technical milestone evidence.

396
True Anomaly Centennial
lowweak
Opp 1
Risk 1

Thesis: Potential long-horizon opportunity cannot be established from available evidence. The reviewed sources membership rationale says the company was selected in the U.S. Space Force Andromeda contract for space surveillance, but no direct within the recent evidence window evidence or article details are available for scoring.

Why now: Why-now visibility is weak because the reviewed sources show zero evidence kept after recent evidence window for this company, so any claimed contract relevance lacks scoreable supporting detail in the current batch.

Caveats: Reviewed evidence cites: in membership rationale but does not provide article summary or available evidence, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Absence of negative evidence is not positive evidence.

397
ULA
lowweak
Opp 1
Risk 1

Thesis: ULA is identified as a launch provider in membership context, but the reviewed sources retains no 90-day positive evidence to support an investable long-horizon opportunity view.

Why now: Coverage data shows zero retained article IDs and evidence after the recent evidence filter, so there is no recent thesis-driving evidence in the reviewed sources.

Caveats: Only membership-level context is present in the served reviewed sources. No direct event, fact, or article-context evidence remains within the recent evidence window. Direction cannot be inferred from category membership alone.

398
Uncovr
lowweak
Opp 1
Risk 1

Thesis: A funding-roundup mention suggests some financing activity, but the reviewed sources have no usable direct positive evidence after recent evidence window and does not connect the company to a space-specific thesis.

Why now: The only described context is a funding-roundup article referenced in phase2 rationale, but no post-recent evidence window evidence or are provided for thesis use.

Caveats: Phase2 rationale says Uncovr was listed as having raised $7M in article: but no was provided in the reviewed sources. Despite support_counts mentioning dated event/facts, the company-level available evidence arrays are empty and coverage data shows evidence after recent evidence window = 0. Broad funding roundup context is weaker than direct company-specific event evidence.

399
United Launch Alliance
lowweak
Opp 1
Risk 1

Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the 90-day recent evidence window, despite membership rationale identifying ULA as a rocket company tied to Vulcan and Atlas V contexts.

Why now: Why now is unsupported because the reviewed sources contain no surviving article or evidence after the selected recent evidence window; business-state or catalyst timing cannot be judged from the provided materials.

Caveats: Zero evidence survived after recent evidence filtering. Company membership in the cohort is not thesis attractiveness. No dated catalyst, performance update, or direct risk item is included.

400
Univity
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources indicates Univity is a satellite startup that raised capital and plans a large VLEO constellation, but no dated within the recent evidence window evidence or article summaries are available here to support a stronger positive thesis.

Why now: No usable within the recent evidence window evidence were available after filtering; recency-based thesis formation is therefore not supported in these reviewed sources.

Caveats: Coverage after recent evidence window is effectively empty in these reviewed sources. Membership rationale is not directional proof.

Risk view

Showing rows 361-380 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
361
Safran
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources also does not provide direct adverse evidence within the available 90-day evidence set, so there is no basis for a material risk thesis beyond uncertainty from missing evidence coverage.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported.

Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff.

362
Sanyark Space Technologies
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available. Risk is mainly that accelerator inclusion alone is too weak to support a durable company thesis, especially over a 1 year+ horizon without proof of funding, contracts, or product milestones (: not provided in reviewed sources).

Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure.

Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available.

363
SatLeo Labs
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources.

Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale.

Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window.

364
SatVu
lowweak
Opp 2
Risk 1

Thesis: No retained within the recent evidence window direct negative evidence is provided in the reviewed sources.

Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy.

Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score.

365
Scale AI
lowweak
Opp 2
Risk 1

Thesis: The risk case is limited by lack of direct adverse evidence in the reviewed sources; the primary risk is evidentiary rather than operational because no retained post-recent evidence window event details, award sizing to the company, or execution milestones are available.

Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope.

Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion.

366
Schaeffler AG
lowweak
Opp 2
Risk 1

Thesis: No material negative evidence is available within the reviewed sources recent evidence window. Risk remains low on evidence, not necessarily in reality.

Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence.

Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources.

367
SciTec
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is retained, leaving no evidence-based risk case.

Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter.

Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window.

368
SEALCOIN AG
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is retained.

Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window.

Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself.

369
SEALSQ Corp
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources also provides no retained material adverse evidence, leaving risk unsupported beyond baseline uncertainty.

Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff.

Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction.

370
SES S.A.
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available for SES. Risk score remains low because of lack of evidence, not because risk has been disproven.

Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources.

Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity.

371
Sidus Space Inc.
lowweak
Opp 1
Risk 1

Thesis: No within the recent evidence window direct negative evidence was available, so the reviewed sources does not support a material risk thesis.

Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources.

372
SkyFi
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is available, so there is no supportable downside thesis from these reviewed sources alone.

Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided.

Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

373
Skyfora
lowweak
Opp 1
Risk 1

Thesis: There is no retained direct adverse evidence in the reviewed sources after recent evidence window, so any risk thesis would be speculative rather than evidence-based.

Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded.

Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof.

374
Solestial Inc.
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis is supportable from these reviewed sources because no retained direct negative evidence is provided inside the recent evidence window.

Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window.

Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof.

375
Solstar Space Company
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is available, so there is no supported adverse thesis from the evidence provided.

Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status.

Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative.

376
Space Mission Systems
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available. The main risk is identity ambiguity and insufficient grounding rather than a demonstrated adverse development.

Why now: The only potential 'why now' is contract-related context in the membership rationale, but it is not sufficiently tied to this entity and no dated scoring evidence with is available.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Entity identification is unclear in the reviewed sources.

377
Space Systems/Loral, LLC (SSL)
lowweak
Opp 1
Risk 1

Thesis: No direct adverse evidence is available in the reviewed sources, so risk stays low purely due to missing evidence rather than demonstrated resilience.

Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources.

Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window.

378
Space42
lowweak
Opp 1
Risk 1

Thesis: No retained adverse evidence is provided, so there is no material evidence-based risk thesis in these reviewed sources.

Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window.

Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

379
Spaceflux
lowweak
Opp 3
Risk 1

Thesis: No material negative evidence is available. The main risk is that the cited funding amount may be too small to be strategically meaningful, but the reviewed sources does not provide direct adverse evidence or enough detail to rank this as a strong risk name (: not provided in reviewed sources).

Why now: A follow-on investment could matter over 1 year+ if it extends development in debris tracking, but there is no available dated evidence within the recent evidence window and no direct article summary/ in the reviewed sources.

Caveats: Only article-level rationale is available. Funding size may be modest, but reviewed sources does not provide enough context to judge materiality precisely. No representative article or quote available.

380
SpaceLocker
lowweak
Opp 1
Risk 1

Thesis: There is not enough retained evidence in the recent evidence window to support a material risk thesis.

Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking.

Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially.